Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.
about
Recent developments in Duchenne muscular dystrophy: facts and numbers.Pharmacological inhibition of REV-ERB stimulates differentiation, inhibits turnover and reduces fibrosis in dystrophic muscle.Duchenne and Becker Muscular Dystrophies: A Review of Animal Models, Clinical End Points, and Biomarker Quantification.Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.Myopenia and precision (P4) medicine.Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy.
P2860
Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@en
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@nl
type
label
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@en
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@nl
prefLabel
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@en
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@nl
P2860
P356
P1476
Cellular Reprogramming, Genome ...... f Duchenne Muscular Dystrophy.
@en
P2093
Huaigeng Xu
P2860
P304
P356
10.1155/2017/8765154
P577
2017-05-15T00:00:00Z